This action might not be possible to undo. Are you sure you want to continue?
Trade Name Classification Dose Route Time/frequency Oseltamivir/placebo Tamiflu/placebo antiviral 6.25 mL PO BID 0900, 2100 clinical trial Peak Onset Duration For IV meds, compatibility with IV Unknown unknown 12 hr drips and /or solutions N/A Mechanism of action and indications (Why med ordered) Inhibits the enxyme neuramidase, which may alter virus particle aggregation and release. Influenza B Nursing Implications (what to focus on) Contraindications/warnings/interactions Hypersensitivity Common side effects None common or life threatening Lab value alterations caused by medicine None known
Interactions with other patient drugs, OTC or herbal medicines (ask patient specifically) None known
Nursing Process- Assessment (Pre-administration assessment) monitor flu symptoms (sudden onset of fever, cough, headache, fatigue, muscular weakness, sore throat)
Be sure to teach the patient the following about this medication Take as soon as flu symptoms appear and continue to take as directed even if symptoms improve. Do not share this medication. This medication is not a substitute for an influenza immunization. Advise practitioner of any other medications being taken. Assessment Evaluation Why would you hold or not Check after giving give this med? Reduction of the Unexpected, intolerable duration of flu adverse effects symptoms